Everist Genomics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Everist Genomics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012894
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Everist Genomics Inc (Everest Health), formerly Genetics Squared Inc is a developer of prognostics, medical diagnostic and therapeutic selection technologies. The company provides angiodefender cardiovascular disease diagnostic system, a non invasive device that is used for combining sensor technology with software algorithm, and allows healthcare providers to assess presence of early stage CVD and atherosclerosis. It offers solutions for cancer, cardiovascular disease and metabolic diseases. Everest Health’s products are used in early diagnosis of atherosclerosis and cardiovascular disease treatments. The company markets its products in the UK, the UAE, the US, India and Canada. Everest Health is headquartered in Ann Arbor, Michigan, the US.

Everist Genomics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Everist Genomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Everist Genomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Everist Genomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Everist Genomics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Everist Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Everist Genomics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Everist Genomics Enters Into Licensing Agreement With Rutgers For Cardiovascular Disease Monitoring Sensor Technology 10
Everist Genomics Enters Into Joint Venture Agreement With Manipal Group 11
Acquisition 12
Everist Genomics Acquires Angiologix 12
Everist Genomics Inc – Key Competitors 13
Everist Genomics Inc – Key Employees 14
Everist Genomics Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Product News 16
01/26/2016: Breakthrough AngioDefender test assesses your risk for cardiovascular disease 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Everist Genomics Inc, Medical Equipment, Key Facts 2
Everist Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Everist Genomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Everist Genomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Everist Genomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Everist Genomics Inc, Deals By Market, 2011 to YTD 2017 8
Everist Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Everist Genomics Enters Into Licensing Agreement With Rutgers For Cardiovascular Disease Monitoring Sensor Technology 10
Everist Genomics Enters Into Joint Venture Agreement With Manipal Group 11
Everist Genomics Acquires Angiologix 12
Everist Genomics Inc, Key Competitors 13
Everist Genomics Inc, Key Employees 14
Everist Genomics Inc, Subsidiaries 15

★海外企業調査レポート[Everist Genomics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Denizbank A.S.:企業の戦略・SWOT・財務分析
    Denizbank A.S. - Strategy, SWOT and Corporate Finance Report Summary Denizbank A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Symphony Ltd:企業の戦略・SWOT・財務分析
    Symphony Ltd - Strategy, SWOT and Corporate Finance Report Summary Symphony Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • International Finance Corp:企業の戦略的SWOT分析
    International Finance Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Continental AG:企業のM&A・事業提携・投資動向
    Continental AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Continental AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Diana S.A.S.:戦略・SWOT・企業財務分析
    Diana S.A.S. - Strategy, SWOT and Corporate Finance Report Summary Diana S.A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Swiss AviationSoftware Ltd.:企業の戦略的SWOT分析
    Swiss AviationSoftware Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Morinaga & Co., Ltd. (2201):企業の財務・戦略的SWOT分析
    Morinaga & Co., Ltd. (2201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Ego Pharmaceuticals Pty Ltd:企業の戦略的SWOT分析
    Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Skanska AB (SKA B):企業の財務・戦略的SWOT分析
    Skanska AB (SKA B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Graham Group Ltd:企業の戦略・SWOT・財務情報
    Graham Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Graham Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nick Scali Ltd (NCK):企業の財務・戦略的SWOT分析
    Nick Scali Ltd (NCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Etrion Corp (ETX):企業の財務・戦略的SWOT分析
    Summary Etrion Corp (Etrion) formerly PetroFalcon Corp, is a solar energy development company. The company produce power and builds, owns and operates utility-scale solar power generation plants. It develops greenfield solar power projects in Japan and Chile. Etrion owns and operates 56.7 MW of sola …
  • Assembly Biosciences Inc (ASMB):企業の財務・戦略的SWOT分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • Grupa Lotos SA (LTS):石油・ガス:M&Aディール及び事業提携情報
    Summary Grupa Lotos S.A. (Grupa Lotos) is an integrated energy company. The company carries out various activities such as the extraction and refining of crude oil; processing of petroleum into finished products; and the wholesale and retail distribution and sale of petroleum products. Its product p …
  • Unimedic AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Unimedic AB (Unimedic), formerly Ergobe Pharma AB, a subsidiary of MedCap AB, is a pharmaceutical company which develops, manufactures, distributes and markets pharmaceutical products. The company offers non-licensed, extemporaneous, and licensed pharmaceuticals targeting the therapy areas w …
  • Chennai Meenakshi Multispeciality Hospital Ltd (523489):企業の財務・戦略的SWOT分析
    Chennai Meenakshi Multispeciality Hospital Ltd (523489) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’ …
  • Dimension Data Holdings Plc:企業の戦略的SWOT分析
    Dimension Data Holdings Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Concordia International Rx UK Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Concordia International Rx UK Ltd (Concordia International), formerly Amdipharm Mercury Company Ltd, a subsidiary of Concordia International Corp, is a manufacturer of pharmaceutical products and orphan drugs. The company’s products include acetazolamide, adenosine, adrenaline acid tartrate, …
  • Hartford HealthCare Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Hartford HealthCare Corp (HHC) is a healthcare service provider that offers clinical care, education and research services. The organization's services include behavioral and mental health, bone and joint care, cancer, cardiology and heart care, dermatology, diabetes and endocrinology, diges …
  • Vaccinex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that discovers and develops targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include antibody platform and ActivMAb, SEMA4D, and antibody d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆